Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01AXK
|
|||
| Drug Name |
Antibodie derivative 10
|
|||
| Synonyms |
PMID28621580-Compound-WO2016057726
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Angiogenesis disorder [ICD-11: BE2Z] | Patented | [1], [2] | |
| Neoplasm [ICD-11: 2A00-2F9Z; ICD-10: C76-C80] | Patented | [1], [2] | ||
| Company |
KADMON CORPORATION, LLC
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Sep;27(9):987-1004. | |||
| REF 2 | Microsomal prostaglandin E2 synthase-1 inhibitors: a patent review.Expert Opin Ther Pat. 2017 Sep;27(9):1047-1059. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.